Kamuzu Central Hospital is a tertiary referral hospital in the city of Lilongwe. It is estimated to have 780 beds, although the true number of patients always exceeds the number of beds.

There are 780 beds in Kamuzu Central Hospital.

During the past decade, Kamuzu Central Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kamuzu Central Hospital" #1 sponsor was "Save the Children" with 3 trials, followed by "University of North Carolina, Chapel Hill" with 3 trials sponsored, "Chinese University of Hong Kong" with 1 trials sponsored, "Clinton Health Access Initiative Inc." with 1 trials sponsored and "HIV Prevention Trials Network" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kamuzu Central Hospital" #1 collaborator was "Kamuzu Central Hospital" with 3 trials as a collaborator, "University of North Carolina" with 3 trials as a collaborator, "University of Washington" with 3 trials as a collaborator, "Kamuzu University of Health Sciences" with 2 trials as a collaborator and "African Esophageal Cancer Consortium (AfrECC)" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Kamuzu Central Hospital" are "Pneumonia" (3 trials), "AIDS-Related Opportunistic Infections" (1 trials), "Acute HIV Infection" (1 trials), "Bacterial Meningitis" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Kamuzu Central Hospital" in a lesser frequency.

Most popular intervention types in "Kamuzu Central Hospital" are "Device" (4 trials), "Other" (4 trials), "Drug" (3 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amoxicillin" (2 trials), "Placebo" (2 trials), "Assessment of patient-reported outcomes (PROs)" (1 trials), "BiliSpec" (1 trials) and "DREAMM" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kamuzu Central Hospital" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kamuzu Central Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kamuzu Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kamuzu Central Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".